- Home
- Publications
- Publication Search
- Publication Details
Title
Applications of Liquid Biopsy for Surgical Patients With Cancer
Authors
Keywords
-
Journal
JAMA Surgery
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2023-11-01
DOI
10.1001/jamasurg.2023.5394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
- (2023) Daisuke Kotani et al. NATURE MEDICINE
- Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer
- (2022) Marwan Fakih et al. JAMA Network Open
- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
- (2022) Jeanne Tie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating tumor DNA analysis for assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients.
- (2021) Tenna V Henriksen et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients
- (2021) Aparna R. Parikh et al. CLINICAL CANCER RESEARCH
- A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer
- (2021) Yuma Wada et al. GASTROENTEROLOGY
- Microsatellite Instability in Colorectal Cancer Liquid Biopsy—Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker
- (2021) Francis Yew Fu Tieng et al. Diagnostics
- Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial
- (2021) Richard A. Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
- (2021) Roberto Alva-Ruiz et al. ANNALS OF SURGICAL ONCOLOGY
- Humoral Predictors of Malignancy in IPMN: A Review of the Literature
- (2021) Enrico C. Nista et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
- (2021) Christian Rolfo et al. Journal of Thoracic Oncology
- Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
- (2021) Maggie Banys-Paluchowski et al. Oncology Research and Treatment
- Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
- (2020) Yoshiaki Nakamura et al. NATURE MEDICINE
- Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
- (2020) Hiu Ting Chan et al. Cancers
- The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
- (2020) Sakti Chakrabarti et al. Cancers
- Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
- (2019) Natasha B. Leighl et al. CLINICAL CANCER RESEARCH
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
- (2019) Jason K. Sicklick et al. NATURE MEDICINE
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- Wake Up and Smell the Fusions: Single-Modality Molecular Testing Misses Drivers
- (2019) Kurtis D. Davies et al. CLINICAL CANCER RESEARCH
- Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
- (2019) Marzia Del Re et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
- (2018) Francesco Passiglia et al. Scientific Reports
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
- (2018) Massimo Cristofanilli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review
- (2017) Gaowei Fan et al. PLoS One
- Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
- (2016) Yilin Li et al. BRITISH JOURNAL OF CANCER
- Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database
- (2016) Manish A. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Unknown
- (2015) CANCER
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study
- (2015) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- Detection of Circulating Tumor Cells from Lung Cancer Patients in the Era of Targeted Therapy : Promises, Drawbacks and Pitfalls
- (2014) V. Hofman et al. CURRENT MOLECULAR MEDICINE
- Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
- (2014) Jeffrey B. Smerage et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
- (2014) Arjan Gower et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
- (2012) Tateaki Naito et al. Journal of Thoracic Oncology
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
- (2009) S. J. Cohen et al. ANNALS OF ONCOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started